Janet Huancachoque

Janet Huancachoque


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2021 in medRxiv
Verified
Preprint
Open access
PDF file
PRPedro E. Romero
Pedro E. Romero
Alejandra Dávila-BarclayAlejandra Dávila-Barclay
Alejandra Dávila-Barclay
GSGuillermo Salvatierra
Guillermo Salvatierra
LGLuis González
Luis González
DADiego Bernhard Cuicapuza Arteaga
Diego Bernhard Cuicapuza Arteaga
PTPablo Tsukayama
Pablo Tsukayama
We report the emergence of a novel lineage of SARS-CoV-2 in South America, termed C.37. It presents seven nonsynonymous mutations in the Spike gene (Δ247-253, G75V, T76I, L452Q, F490S, T859N) and a deletion in the ORF1a gene (Δ3675-3677) also found in variants of concern (VOCs) Alpha, Beta, and Gamma. Initially reported in Lima, Peru, in late December 2020, it now accounts for 97% of Peruvian public genomes in April 2021. It is expanding in Chile and Argentina, and there is evidence of onward transmission in Colombia, Ecuador, Mexico, the USA, Germany, and Israel. On June 15, 2021, the World Health Organization designated C.37 as Variant of Interest (VOI) Lambda.

19 July 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
KQKaren Eugenia Quispe
Karen Eugenia Quispe
ALBERTO SALAZAR GRANARAALBERTO SALAZAR GRANARA
ALBERTO SALAZAR GRANARA
MTMario Cueva Távara
Mario Cueva Távara
JHJanet Huancachoque
Janet Huancachoque
Diego Segura LoayzaDiego Segura Loayza
Diego Segura Loayza
PCPool Marcos Carbajal
Pool Marcos Carbajal
Multidrug-resistant (MDR) Klebsiella pneumoniae is a critical cause of nosocomial infections associated with high mortality. Of particular concern is the genomic convergence of multidrug resistance and hypervirulence (MDR-hvKP), which represents a severe public health threat. This study characterised the resistome, virulome, and population structure of seven clinical MDR K. pneumoniae isolates collected between 2024 and 2025 across four Peruvian regions (Moquegua, Ucayali, Loreto, and Lima) using whole-genome sequencing (WGS). Genomic analysis identified six distinct sequence types, with the high-risk clone ST307 being the most prevalent (2/7 isolates), consistently associated with the KL102 capsular locus. Remarkably, one isolate from Loreto (oph_54) exhibited a convergent MDR-hvKP genomic profile (ST218, KL57, virulence score 4), carrying yersiniabactin, salmochelin (iro), and aerobactin (iuc) loci alongside multiple resistance determinants. The isolates presented a robust resistome dominated by the extended-spectrum beta-lactamase gene blaCTX-M-15 (5/7) and blaOXA-1, coupled with aac(6′)-Ib-cr and fosA6 genes. Plasmid analysis revealed a predominance of IncFIB(K) replicons. Although exploratory, these findings demonstrate the regional presence of high-risk ST307 lineages and the emergence of convergent MDR-hvKP genomic profiles within the analysed Peruvian hospitals. Immediate and continuous genomic surveillance is urgently required to monitor the potential spread of these highly dangerous, MDR bacterial lineages within these healthcare environments.